Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone

JIANG Hai-wei1; HE Dan-feng2; XIAO Hui-quan3

doi:10.13288/j.11-2166/r.2008.11.050

您当前的位置：

首页 >

文章列表页 >

Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone

更新时间：2021-11-17

- Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone
- Journal of Traditional Chinese Medicine Issue 11, Pages: 981-983(2008)
- 作者机构：
  
  1. 湖北省中山医院亚健康管理中心
  2. 湖北省中山医院内科
  3. 广州中医药大学第一附属医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2008.11.050
  CLC： R575.5;R587.1
- Published：2008
- 稿件说明：
移动端阅览
[1]姜海伟,和单凤,肖会泉.健脾益肾、活血化痰法联合罗格列酮早期治疗非酒精性脂肪肝并胰岛素抵抗29例临床观察[J].中医杂志,2008(11):981-983.

JIANG Hai-wei1, HE Dan-feng2, XIAO Hui-quan3. Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone[J]. Journal of Traditional Chinese Medicine2008, (11): 981-983.
[1]姜海伟,和单凤,肖会泉.健脾益肾、活血化痰法联合罗格列酮早期治疗非酒精性脂肪肝并胰岛素抵抗29例临床观察[J].中医杂志,2008(11):981-983. DOI： 10.13288/j.11-2166/r.2008.11.050.

JIANG Hai-wei1, HE Dan-feng2, XIAO Hui-quan3. Clinical Study on 29 Cases of Nonalcoholic Fatty Liver Disease with Insulin Resistance Treated by Strengthening Spleen,Tonifying Kidney,Invigorating Blood Flow and Dissolving Phlegm plus Rosiglitazone[J]. Journal of Traditional Chinese Medicine2008, (11): 981-983. DOI： 10.13288/j.11-2166/r.2008.11.050.

摘要

目的探讨健脾益肾、活血化痰法联合罗格列酮对非酒精性脂肪肝并胰岛素抵抗的早期治疗意义。方法90例患者随机分为空白组29例、西药组（口服罗格列酮）32例、治疗组（口服罗格列酮和健脾益肾、活血化痰方）29例

1个月为1个疗程

共2个疗程。观察治疗前后肝功能、血脂、空腹血糖（FBG）、空腹胰岛素（FINS）、胰岛素抵抗指数（IRI）、血清瘦素、脂联素的变化。结果治疗组患者肝功能、血脂、FBG、FINS、IRI、瘦素、脂联素与治疗前比较差异均有统计学意义（P<0.05或<0.01）;与西药组比较

在改善γ-谷氨酰转肽酶（GGT）及FINS方面差异有统计学意义（P<0.05或<0.01）。治疗组总有效率79.31%。结论健脾益肾、活血化痰法联合罗格列酮早期干预非酒精性脂肪肝并胰岛素抵抗有着较好的临床意义。

Abstract

Objective To observe the effect of herbal treatment to strengthen spleen

tonify kidney

invigorate blood flow and dissolve phlegm plus Rosiglitazone on nonalcoholic fatty liver disease （NAFLD） with insulin resistance （IR）.Methods The 90 cases were randomized into 3 groups:blank group of 29 cases;western medicine group of 32 cases

treated with Rosiglitazone;treatment group of 29 cases treated with herbal medicine plus Rosiglitazone.The changes in liver function

blood lipid

fasting blood glucose （FBG）

fasting insulin （FIN）

insulin resistance index （IRI）

serum leptin and adiponcetin were observed.Results In the treatment group

changes of liver function

blood lipid

FBG

FIN

IRI

serum leptin and adiponcetin compared after treatment was significant （P<0.05 or P<0.01）;compared with the western medicine group

the improvement in glutamyl transferase （GGT） and FINS was significant （P<0.05 or P<0.01）.The total effective rate of the treatment group was 79.31%.Conclusion The herbal treatment with the principle to strengthen spleen

tonify kidney

invigorate blood flow and dissolve phlegm plus Rosiglitazone was effective for NAFLD with IR.

关键词

Keywords

references

查看原文

Views

150

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

电针在多囊卵巢综合征患者辅助生殖领域中的应用及相关机制研究进展

Effects of Root-Tip Points Combination Electro-Acupuncture on Insulin Sensitivity and the Expression of SIRT1 Protein in Skeletal Muscle of Rats with Insulin Resistance

Clinical Observation on 66 Cases of Diabetes Ⅱ with Qi Deficinecy and Phlegm-turbid Syndrome Treated by Jiangzhuo Mixture

Exploring the Comorbidity Mechanism，Prevention and Treatment Strategies of Rheumatoid Arthritis with Coronary Atherosclerotic Heart Disease Based on Collateral Disease Theory

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Related Author

李家希

王艺绚

董丽

吴海萃

连方

辛欣

LIU Jianmin

WU Hongyang

Related Institution

山东中医药大学，山东省济南市历下区经十路16369号

山东中医药大学附属医院

Hubei University of Chinese Medicine

Union Hospital Tongji Medical College Huazhong University of Science and Technology

Wuhan Integrative Medicine Hospital

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰